Lantheus Holdings Inc
SWB:0L8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lantheus Holdings Inc
SWB:0L8
|
US |
|
Coastal Financial Corp (EVERETT)
F:1VD
|
US |
|
GoldON Resources Ltd
XTSX:GLD
|
CA |
|
N
|
Northern Lion Gold Corp
XTSX:NL
|
CA |
|
BTC Health Ltd
ASX:BTC
|
AU |
|
C
|
China Travel International Investment Hong Kong Ltd
XMUN:CTI
|
HK |
|
D
|
Del Monte Corp
SWB:FDM
|
KY |
|
F
|
Flutter Entertainment PLC
SWB:PPB
|
US |
Intrinsic Value
Is 0L8 undervalued or overvalued?
See the intrinsic value estimate for 
Lantheus Holdings Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Lantheus Does
Lantheus Holdings makes diagnostic products that help doctors see disease inside the body, especially in cancer and heart imaging. Its main products are imaging agents used with PET, SPECT, ultrasound, and other scans, including the prostate cancer tracer PYLARIFY and the ultrasound contrast agent DEFINITY. These products do not treat patients directly; they help hospitals and imaging centers find and track disease more accurately.
- Headquarters
- United States of America US
- Employees
- 1 193
- IPO date
- Jun 25, 2015
Lantheus Holdings has a wide economic moat
Lantheus Holdings Inc possesses a wide economic moat, providing strong and durable advantages that protect its market position and profitability.
Read the full moat analysis
Revenue & Expenses Breakdown
Lantheus Holdings Inc
Earnings Waterfall
Lantheus Holdings Inc
The intrinsic value for Lantheus Holdings Inc (0L8) under the Base Case is hidden EUR.
Compared with the current market price of 87.6 EUR, the stock appears hidden.
